alexa High-Cost Generic Drugs — Implications for Patients and Policymakers
Medicine

Medicine

Journal of Forensic Medicine

Author(s): Jonathan D Alpern, William M Stauffer, Aaron S Kesselheim

Abstract Share this page

It is well known that new brand-name drugs are often expensive, but U.S. health care is also witnessing a lesser-known but growing and seemingly paradoxical phenomenon: certain older drugs, many of which are generic and not protected by patents or market exclusivity, are now also extremely expensive. Take the case of albendazole, a broad-spectrum antiparasitic medication. Albendazole was first marketed by a corporate predecessor to GlaxoSmithKline (GSK) outside the United States in 1982 and was approved by the Food and Drug Administration (FDA) in 1996. Its patents have long since expired, but no manufacturer ever sought FDA approval for a generic version. One reason may be that the primary indications for the drug — intestinal parasites, neurocysticercosis, and hydatid disease — occur relatively rarely in the United States and usually only in disadvantaged populations such as immigrants and refugees. In late 2010, the listed average wholesale price (AWP) for albendazole was $5.92 per typical daily dose in the United States and less than $1 per typical daily dose overseas.

  • To read the full article Visit
  • Open Access
This article was published in N Engl J Med and referenced in Journal of Forensic Medicine

Relevant Expert PPTs

Relevant Speaker PPTs

  • Veronica La Regina
    Veronica-La-Regina-Italian-Space-Agency-(ASI)-Italy-Systems-engineering-approach-and-space-technology-transfer-The-role-of-international-relations-and-public-policy
    PPT Version | PDF Version

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords